Table 1 Demographic, anthropometric, laboratory and clinical characteristics of IHD and control patients
From: Plasma and pericardial fluid metabolomic signatures of patients with ischemic heart disease
Characteristic | Mitral insufficiency (Control, n = 10) | IHD (n = 10) | p-value3 |
|---|---|---|---|
Age | 57.1 (8.70) | 60,9 (5,74) | 0.4 |
Sex | >0.3 | ||
F | 2 (20%) | 2 (20%) | |
M | 8 (80%) | 8 (80%) | |
BMI, Kg/m2 2 | 26.7 (1.34) | 27.50 (1.51) | 0.3 |
Smokers1 | 4 (40%) | 3 (30%) | 0.9 |
Ex-Smokers1 | 2 (20%) | 2 (20%) | 0.9 |
Familiarity1 | 1 (10%) | 5 (50%) | 0.14 |
Medication1 | 4 (40%) | 5 (50%) | >0.9 |
LDL Cholesterol, mg/dl2 | 104 (20) | 110 (16) | 0.9 |
WBC, 103/µl 2 | 8.30 (1.45) | 7.42 (1.48) | 0.4 |
RBC, 106/µl 2 | 4.50 (0.33) | 4.88 (0.61) | 0.072 |
Hb g/dl 2 | 13.22 (1.30) | 14.56 (1.82) | 0.062 |
Hct 2 | 39.0 (3.3) | 42.5 (4.98) | 0.071 |
PLT, 103/µl 2 | 235 (60) | 202 (70) | 0.5 |
Fibrinogen, mg/dl 2 | 422 (138) | 358 (126) | 0.4 |
Glucose, mg/dl 2 | 91.7 (6.1) | 90.6 (4.7) | >0.9 |
Creatinine, mg/dl 2 | 0.87 (0.18) | 0.84 (0.14) | 0.7 |
Got-Ast, UI/l 2 | 17.4 (4.6) | 21.0 (5.2) | 0.2 |
Gpt-Alt, UI/l 2 | 21 (10) | 21 (8) | 0.9 |
CPK, UI/l 2 | 76 (54) | 107 (44) | 0.2 |
CPK-MB, UI/l2 | 13.7 (6.9) | 13.5 (5.7) | >0.9 |
